Daniel Sharp

Daniel Sharp

Director/Miembro de la Junta en ALCIDION GROUP LIMITED .

Fortuna: 181 571 $ al 30/09/2026

Health Technology
Finance
Consumer Services

Perfil

Mr. Daniel Sharp, CFA, is an Independent Non-Executive Director at Alcidion Group Ltd. He is on the Board of Directors at Botanix Pharmaceuticals Ltd. and Alcidion Group Ltd. Mr. Sharp was previously employed as an Independent Non-ExecutiveDirector by ImpediMed Ltd., an Independent Non-Executive Director by Race Oncology Ltd., an Executive Director by Canaccord Genuity (Australia) Ltd., and an Executive Director by Shaw & Partners Corporate Finance Pty Ltd. He received his undergraduate degree from Monash University and a graduate degree from Monash University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
30/06/2025 1.378.572 ( 0,1 % ) 105 502 $ 30/09/2026
17/10/2026 6.075.791 ( 0,22 % ) 76 069 $ 30/09/2026

Cargos activos de Daniel Sharp

EmpresasCargoInicio
ALCIDION GROUP LIMITED Director/Miembro de la Junta 01/09/2021

Antiguos cargos conocidos de Daniel Sharp.

EmpresasCargoFin
BOTANIX PHARMACEUTICALS LIMITED Director/Miembro de la Junta 17/10/2026
IMPEDIMED LIMITED Director/Miembro de la Junta 28/09/2023
RACURA ONCOLOGY LTD Director/Miembro de la Junta 29/06/2023
Director/Miembro de la Junta 01/01/2020
Corporate Officer/Principal -
Ver el detalle de la experiencia de Daniel Sharp.

Formación de Daniel Sharp.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

71

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Consumer Services

Health Technology

Finance

Technology Services

Finance

Health Technology